Comparison of US and EU Prices for Orphan Drugs in the Perspective of the Considered US Orphan Drugs Act Modifications and Discussed Price-Regulation Mechanisms Adjustments in US and European Union

The 2019 worldwide sales of Orphan Drugs were estimated at $136 billion USD, which constituted 16% of the global pharmaceutical prescription market and is expected to grow by 12% in the next 5 years. A better understanding of Orphan Drug pricing may contribute to on-going discussions on Orphan Drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Żelewski, Paweł, Wojna, Michał, Sygit, Katarzyna, Cipora, Elżbieta, Gąska, Izabela, Niemiec, Mateusz, Kaczmarski, Mateusz, Banaś, Tomasz, Karakiewicz, Beata, Kotwas, Artur, Zabielska, Paulina, Partyka, Olga, Pajewska, Monika, Krzych-Fałta, Edyta, Bandurska, Ewa, Ciećko, Weronika, Czerw, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566473/
https://www.ncbi.nlm.nih.gov/pubmed/36231399
http://dx.doi.org/10.3390/ijerph191912098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566473/
https://www.ncbi.nlm.nih.gov/pubmed/36231399
http://dx.doi.org/10.3390/ijerph191912098

Ejemplares similares